{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:40:41Z","timestamp":1789908041267,"version":"4.0.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":6750,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1023\/a:1011132808904","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T06:26:45Z","timestamp":1040624805000},"page":"991-995","source":"Crossref","is-referenced-by-count":223,"title":["Thalidomide and dexamethasone combination for refractory multiple myeloma"],"prefix":"10.1016","volume":"12","author":[{"given":"M.A.","family":"Dimopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Zervas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kouvatseas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Galani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Grigoraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ch.","family":"Kiamouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Vervessou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Samantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ch.","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Economou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Panayiotidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Christakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Anagnostopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1023\/A:1011132808904_bb0010","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJM199402173300709","article-title":"The treatment of multiple myeloma","volume":"330","author":"Alexanian","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1011132808904_bb0015","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","article-title":"Antitumor activity of thalidomide in refractory multiple myeloma","volume":"341","author":"Singhal","year":"1999","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1023\/A:1011132808904_bb0020","first-page":"604a","article-title":"Thalidomide alone or with dexamethasone for multiple myeloma","volume":"94","author":"Weber","year":"1999","journal-title":"Blood"},{"key":"10.1023\/A:1011132808904_bb0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1023\/A:1011132808904_bb0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Bull"},{"key":"10.1023\/A:1011132808904_bb0035","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1200\/JCO.1983.1.11.710","article-title":"Analysis of survival by tumor response","volume":"1","author":"Anderson","year":"1983","journal-title":"J Clin Oncol"},{"issue":"Suppl 3","key":"10.1023\/A:1011132808904_bb0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0037-1963(00)90079-9","article-title":"Thalidomide for resistant and relapsing myeloma","volume":"37","author":"Alexanian","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1023\/A:1011132808904_bb0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2141.2000.01983.x","article-title":"Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma","volume":"109","author":"Juliusson","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1023\/A:1011132808904_bb0050","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/sj.thj.6200031","article-title":"Thalidomide in patients with advanced multiple myeloma","volume":"1","author":"Yakoub-Agha","year":"2000","journal-title":"Hematology J"},{"key":"10.1023\/A:1011132808904_bb0055","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJM199911183412110","article-title":"Thalidomide-A revival story","volume":"341","author":"Raje","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1011132808904_bb0060","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood.V96.9.2943","article-title":"Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy","volume":"96","author":"Hideshima","year":"2000","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1023\/A:1011132808904_bb0065","first-page":"167a","article-title":"Thalidomide with dexamethasone for resistant multiple myeloma","volume":"96","author":"Weber","year":"2000","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1023\/A:1011132808904_bb0070","first-page":"168a","article-title":"Thalidomide plus dexamethasone and thalidomide alone as first line therapy for newly diagnosed myeloma","volume":"96","author":"Rajkumar","year":"2000","journal-title":"Blood"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419541874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419541874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/12\/7\/991\/19479645\/12-7-991.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T04:27:49Z","timestamp":1733545669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419541874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["S0923753419541874"],"URL":"https:\/\/doi.org\/10.1023\/a:1011132808904","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}